Isolated hepatic perfusion for lapine liver metastases: Impact of hyperthermia on permeability of tumor neovasculature

Surgery

Volumn 126, Issue 5, 1999, Pages 890-899

  Gnant, Michael F X ^b   Noll, Linda A ^b   Terrill, Richard E ^b   Wu, Peter C ^b   Berger, Adam C ^b   Nguyen, Hung Q ^b   Lans, Titia E ^b   Flynn, Bernard M ^b   Libutti, Steven K ^b   Bartlett, David L ^b   Alexander Jr , H Richard ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; FEMALE; HYPERTHERMIC THERAPY; LIVER METASTASIS; LIVER PERFUSION; METASTASIS INHIBITION; NONHUMAN; PRIORITY JOURNAL; RABBIT; TEMPERATURE SENSITIVITY; TREATMENT OUTCOME; TUMOR VASCULARIZATION;

EID: 0032744575     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(99)70030-9     Document Type: Article

References (31)

1. 1. Daly JM, Kemeny NE. Metastatic cancer to the liver. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. 5th ed. Philadelphia: Lippincott-Raven; 1997, p. 2551-70.
2. 2. Venook AP, Warren RS. Regional chemotherapy approaches for primary and metastatic liver tumors. Surg Oncol Clin N Am 1996;5:411-27.
3. 3. Alexander HR, Bartlett DL, Libutti SK. Isolated hepatic perfusion: a potentially effective treatment for patients with metastatic or primary cancers confined to the liver. Cancer J Sci Am 1998;4:2-11.
4. 4. Alexander HR, Bartlett DL, Libutti SK, Fraker DL, Moser T, Rosenberg SA. Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver. J Clin Oncol 1998;16:1479-89.
5. 5. Ravikumar TS, Dixon K. Isolated liver perfusion for liver metastases: Pharmacokinetic advantage? Surg Oncol Clin N Am 1996;5:443-9.
6. 6. Hahn GM, Strande DP. Cytotoxic effects of hyperthermia and adriamycin on Chinese hamster cells. J Natl Cancer Inst 1976;57:1063-7.
7. 7. Cavaliere R, Ciogatto EC, Giovanelli BC, Heidelberger C, Johnson RO, Margottini M, et al. Selective heat sensitivity of cancer cells. Cancer 1967;20:1351-87.
8. 8. Lin JC, Park HJ, Song CW. Combined treatment of IL-1α and TNF-α potentiates the antitumour effect of hyperthermia. Int J Hyperthermia 1996;12:335-44.
9. 9. Manusama ER, Nooijen PTGA, Hagen TLMT, van der Veen AH, de Vries MWR, de Wilt JHW, et al. Tumor necrosis factor-alpha in isolated perfusion systems in the treatment of cancer: the Rotterdam preclinical-clinical program. Semin Surg Oncol 1998;14:232-7.
10. 10. Skibba JL, Condon RE. Hyperthermic isolalion-perfusion in vivo the canine liver. Cancer 1983;51:1303-9.
11. 11. Skibba JL, Almagro UA, Condon RE, Petroff RJ. A technique for isolation perfusion of the canine liver with survival. J Surg Res 1983;34:123-32.
12. 12. Rous P, Beard JW. The progression to carcinoma of virus-induced rabbit papillomas (SHOPE). J Exp Med 1935;62:523-48.
13. 13. Baba N, von Haam E. Animal model for human disease: adenocarcinoma. Am J Pathol 1972;68:653-6.
14. 14. Kunieda K, Seki T, Nakatani S, Wakabayashi M, Shiro T, Inoue K, et al. Implantation treatment method of slow release anticancer doxorubicin containing hydroxyapatite (DOX-HAP) complex: a basic study of a new treatment for hepatic cancer. Br J Cancer 1993;67:668-73.
15. 15. Shu S, Rosenberg SA. Adoptive immunotherapy of newly induced murine sarcomas. Cancer Res 1985;45:1657-62.
16. 16. Kidd JG, Rous P. A transplantable rabbit carcinoma originating in a virus-induced papilloma and containing the virus in masked or altered form. J Exp Med 1940;71:813-37.
17. 17. Ku Y, Fukumoto T, Tominaga M, Iwasaki T, Maeda I, Kusunoki N, et al. Single catheter technique of hepatic venous isolation and extracorporeal charcoal hemoperfusion for malignant liver tumors. Am J Surg 1997;173:103-9.
18. 18. Ausman RK. Development of a technic for isolated perfusion of the liver. N Y State J Med 1961;61:3393-7.
19. 19. Radnell M, Jeppsson B, Bengmark S. A technique for isolated liver perfusion in the rat with survival and results of cytotoxic drug perfusion on liver tumor growth. J Surg Res 1990;49:394-9.
20. 20. Marinelli A, Van de Velde CJH, Kuppen PJK, Franken HCM, Souverijn JHM, Eggermont AMM. A comparative study of isolated liver perfusion versus hepatic artery infusion with mitomycin C in rats. Br J Cancer 1990;62:891-6.
21. 21. Ghussen F, Nagel K, Isselhard W. Isolated liver perfusion in dogs. Recent Results Cancer Res 1983;86;93-8.
22. 22. Aigner KR, Link KH, Woescher H, Johannes W, Hundeiker M. Regional perfusion of VX 2 carcinoma with cis-DDP. Anticancer Res 1983;3:431-4.
23. 23. Prat F, Centarti M, Sibille A, El Fadil FA, Henry L, Chapelon J-Y, et al. Extracorporeal high-intensity focused ultrasound for VX2 liver tumors in the rabbit. Hepatology 1995;21:832-6.
24. 24. Butler JA, Trezona TP, Nordestgaard A, State D. Hepatic artery versus portal vein and systemic infusion of fluorodeoxyuridine of rabbit VX-2 hepatic implants. Am J Surg 1989;157:126-9.
25. 25. Izumi B, Tashiro S, Miyauchi Y. Anticancer effects of local administration of mitomycin C via the hepatic artery or portal vein on implantation and growth of VX2 cancer injected into rabbit liver. Cancer Res 1986;46:4167-70.
26. 26 Alexander HR, Brown CK, Bartlett DL, Libutti SK, Figg WM, Raje S, et al. Augmented capillary leak during isolated hepatic perfusion (IHP) occurs via tumor necrosis factor independent mechanisms. Clin Cancer Res 1998;4:2357-62.
27. 27. Denekamp J. Vascular endothelium as the vulnerable element in tumors. Acta Radiol Oncol 1984;23:217-25.
28. 28. Fajardo LF, Schreiber AB, Kelly NI, Hahn GM. Thermal sensitivity of endothelial cells. Radiat Res 1985;103:276-85.
29. 29. Nawroth P, Handley D, Matsueda G, de Waal R, Gerlach H, Blohm D, et al. Tumor necrosis factor/cachectin-induced intravascular fibrin formation in meth A fibrosarcomas. J Exp Med 1988;168:637-47.
30. 30. Nawroth PP, Stem DM. Modulation of endothelial cell hemostatis properties by tumor necrosis factor. J Exp Med 1986;163:740-5.
31. 31. Olieman AFT, van Ginkel RJ, Hoekstra HJ, Mooyaart EL, Molenaar WM, Koops HS. Angiographic response of locally advanced soft-tissue sarcoma following hyperthermic isolated limb perfusion with tumor necrosis factor. Ann Surg Oncol 1997;4:64-9.